Two New Roles for Theophylline in the Asthmatic?
- 1 January 1995
- journal article
- review article
- Published by Taylor & Francis in Journal of Asthma
- Vol. 32 (2) , 89-95
- https://doi.org/10.3109/02770909509083229
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Anti-inflammatory effects of low-dose oral theophylline in atopic asthmaThe Lancet, 1994
- Theophylline in the management of asthma: time for reappraisal?European Respiratory Journal, 1994
- What role for theophylline?Thorax, 1994
- Theophylline—an Immunomodulatory Role in Asthma?American Review of Respiratory Disease, 1993
- Inhibition of eosinophil cyclic nucleotide PDE activity and opsonised zymosan‐stimulated respiratory burst by ‘type IV’‐selective PDE inhibitorsBritish Journal of Pharmacology, 1991
- Effects of selective phosphodiesterase inhibitors on the polymorphonuclear leukocyte respiratory burst1Journal of Allergy and Clinical Immunology, 1990
- Polymorphonuclear Leukocyte Inhibition by Therapeutic Concentrations of Theophylline Is Mediated by Cyclic-3′, 5′-Adenosine MonophosphateAmerican Review of Respiratory Disease, 1988
- Protective Effect of Antiasthma Drugs on Late Asthmatic Reactions and Increased Airway Responsiveness Induced by Toluene Diisocyanate in Sensitized SubjectsAmerican Review of Respiratory Disease, 1987
- Therapeutic concentrations of theophylline and enprofylline potentiate catecholamine effects and inhibit leukocyte activationJournal of Allergy and Clinical Immunology, 1986
- The effect of theophylline and enprofylline on allergen-induced bronchoconstrictionJournal of Allergy and Clinical Immunology, 1985